Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of 9-Aminocamptothecin in Advanced Non-Small Cell Lung Cancer
NCT00003154Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 1998
- Primary completion
- Apr 2001
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of 9-aminocamptothecin in non-small cell lung cancer (NSCLC), sponsored by Case Comprehensive Cancer Center. Started Jan 1998; status: completed.
02
Drugs
9-aminocamptothecin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003154.